Genetic correction of the fetal brain increases the lifespan of mice with the severe multisystemic disease mucopolysaccharidosis type VII
Authors:
- John H. WolfeJWJohn H. Wolfe
Open Access
- 1 July 2006
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 14 (1) , 14-24
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Gene therapy for lysosomal storage diseases: the lessons and promise of animal modelsThe Journal of Gene Medicine, 2004
- Intraventricular Brain Injection of Adeno-Associated Virus Type 1 (AAV1) in Neonatal Mice Results in Complementary Patterns of Neuronal Transduction to AAV2 and Total Long-Term Correction of Storage Lesions in the Brains of β-Glucuronidase-Deficient MiceJournal of Virology, 2003
- Inborn errors of metabolism in the Italian pediatric population: A national retrospective surveyThe Journal of Pediatrics, 2002
- Widespread Gene Delivery and Structure-Specific Patterns of Expression in the Brain after Intraventricular Injections of Neonatal Mice with an Adeno-Associated Virus VectorJournal of Virology, 2001
- In Utero Fetal Liver Cell Transplantation without Toxic Irradiation Alleviates Lysosomal Storage in Mice with Mucopolysaccharidosis Type VIIBlood Cells, Molecules, and Diseases, 2001
- In utero transplantation of fetal liver cells in the mucopolysaccharidosis type VII mouse results in low-level chimerism, but overexpression of β-glucuronidase can delay onset of clinical signsBlood, 2001
- Mucopolysaccharidosis Type VII in the Developing Mouse FetusPediatric Research, 2000
- Prevalence of Lysosomal Storage DisordersJAMA, 1999
- Neural progenitor cell engraftment corrects lysosomal storage throughout the MRS VII mouse brainNature, 1995
- LYSOSOMAL STORAGE DISEASESAnnual Review of Biochemistry, 1991